Clinical Experimentation With Tenofovir Disoproxyl Fumarate and Emtricitabine for COVID-19
Condition(s):Covid19Last Updated:January 15, 2021Recruiting
Include Studies Not Open or Pending
Condition(s):Covid19Last Updated:January 15, 2021Recruiting
Condition(s):SARS-CoV 2Last Updated:March 9, 2021Recruiting
Condition(s):Chronic Obstructive Pulmonary DiseaseLast Updated:April 23, 2021Recruiting
Condition(s):Renal Failure; Chronic Kidney Disease Requiring Chronic DialysisLast Updated:May 17, 2022Not yet recruiting
Condition(s):Persistent Post-concussive Syndrome; Concussion Post SyndromeLast Updated:June 1, 2022Recruiting
Condition(s):Benign Intracranial HypertensionLast Updated:February 2, 2021Recruiting
Condition(s):Squamous Cell Carcinoma of the Head and NeckLast Updated:June 27, 2022Recruiting
Condition(s):Oropharyngeal CancerLast Updated:April 22, 2022Recruiting
Condition(s):Pancreas AdenocarcinomaLast Updated:October 15, 2021Recruiting
Condition(s):Muscle Damage; Muscle SorenessLast Updated:October 29, 2021Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.